FeesSafety
Pluang+

Arch Biopartners hires Oak Hill Financial for investor relations and marketing to boost kidney drug program awareness

Company Fundamentals
18 Nov 2026, 15:10 WIB
GlobeNewsWire
View Source
Bullish
Arch Biopartners hires Oak Hill Financial for investor relations and marketing to boost kidney drug program awareness

Arch Biopartners has engaged Oak Hill Financial to provide investor relations and marketing services aimed at increasing awareness of its kidney drug development programs. Oak Hill will reach out to investment advisors and institutions, support investor messaging, and report on strategy and activities. The initial contract is for three months with automatic monthly renewals, paid from Arch's working capital. This partnership aims to enhance investor engagement as Arch advances clinical trials for treatments targeting acute and chronic kidney diseases.

Arch Biopartners engages Oak Hill Financial for investor relations. For readers following health-sector stocks, here is Pluang's market snapshot as of Nov 18, 2026 19:21 WIB: out of 150 priced US health stocks, 55 rose and 86 fell. Notable movers include DNA at USD 8.59 with a 3.25% increase and 100% sell order activity, ABEO at USD 2.68 up 3.08% with 97% sell orders, and SLS at USD 18.61 down 2.82% with a balanced buy-sell order split.

More News

Lowe's beats Q3 earnings estimates and raises full-year sales outlook.

Lowe's beats Q3 earnings estimates and raises full-year sales outlook.

Lowe's reported adjusted earnings per share of $3.10, surpassing estimates of $2.88, and revenue of $22.80 billion, beating the $22.40 billion forecast. Comparable sales rose 1.8%, driven by strong online and professional services sales. The company ...

Company Fundamentals
Bullish
50 minutes ago
Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Daxor Corporation announced that a major Memphis health system has expanded its Blood Volume Analysis (BVA) program to an additional hospital outpatient site using Daxor’s ezBVA Lab service. This expansion allows the outpatient clinic to receive bloo...

Market News
Bullish
54 minutes ago
Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft's stock fell 2.27% to $506.24 following global outages affecting its Copilot, Teams, and Outlook services. The outages, attributed to server issues rather than cyberattacks, raised concerns amid broader software sector weakness. Oppenheimer...

Market News
Bearish
1 hour ago
Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target Corporation reported earnings per share of $2.65, beating estimates of $2.08, and revenue of $27.1 billion, surpassing the $26.5 billion forecast. The company achieved its strongest quarterly sales growth in about five years, with net sales up...

Company Fundamentals
Bullish
1 hour ago
Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics announced its participation in the Piper Sandler 38th Annual Healthcare Conference from December 1-3, 2026, in New York City. CEO Daniel Barber will present on December 2 at 10:30 am ET, with one-on-one investor meetings schedu...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App